Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

NCT03634982 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: RMC-4630

Sponsor

Revolution Medicines, Inc.

Collaborators

[object Object]